Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus
Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus is a paper indexed in PICO Portal from OpenAlex.
How many citations does Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus have?
Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus has 232 citations in the OpenAlex counts PICO Portal stores.
When was Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus published?
Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus has 2008 year in the PICO Portal index.
What is the open-access status of Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus?
Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus has closed oa status in the PICO Portal index.
What is the DOI of Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus?
The DOI for Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus is on the source record.
What is the PMID of Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus?
The PMID for Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus is on the source record.
What is the OpenAlex record for Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus?
The OpenAlex for Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus is on the source record.